AMD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.083600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.329200E-01
Normal-vs-Stage2
5.342600E-01
Normal-vs-Stage3
1.522140E-02
Normal-vs-Stage4
7.990000E-01
Stage1-vs-Stage2
7.580200E-01
Stage1-vs-Stage3
1.218230E-01
Stage1-vs-Stage4
5.576000E-01
Stage2-vs-Stage3
1.037770E-01
Stage2-vs-Stage4
2.987400E-01
Stage3-vs-Stage4
3.718000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.787400E-01
Normal-vs-AfricanAmerican
7.105000E-01
Normal-vs-Asian
1.407840E-01
Caucasian-vs-AfricanAmerican
3.165400E-01
Caucasian-vs-Asian
1.448030E-01
AfricanAmerican-vs-Asian
1.566620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.199800E-01
Normal-vs-Female
6.436800E-01
Male-vs-Female
2.062600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.506400E-01
Normal-vs-Age(41-60Yrs)
7.601200E-01
Normal-vs-Age(61-80Yrs)
4.301600E-01
Normal-vs-Age(81-100Yrs)
2.448600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.002000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.575000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.489800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.096010E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.119200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.559000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.908410E-01
Normal-vs-Daily Drinker
1.534840E-01
Normal-vs-Weekly Drinker
7.348200E-01
Normal-vs-Occasional Drinker
3.150800E-01
Normal-vs-Social Drinker
5.977400E-01
Non Drinker-vs-Daily Drinker
2.742000E-01
Non Drinker-vs-Weekly Drinker
3.955200E-01
Non Drinker-vs-Occasional Drinker
6.437400E-01
Non Drinker-vs-Social Drinker
4.207400E-01
Daily Drinker-vs-Weekly Drinker
1.284380E-01
Daily Drinker-vs-Occasional Drinker
1.983210E-01
Daily Drinker-vs-Social Drinker
1.626000E-01
Weekly Drinker-vs-Occasional Drinker
5.566000E-01
Weekly Drinker-vs-Social Drinker
8.335200E-01
Occasional Drinker-vs-Social Drinker
7.116400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.855200E-01
Normal-vs-Grade 2
9.120800E-01
Normal-vs-Grade 3
8.834600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.317800E-01
Grade 1-vs-Grade 3
8.104200E-01
Grade 1-vs-Grade 4
7.855200E-01
Grade 2-vs-Grade 3
6.274200E-01
Grade 2-vs-Grade 4
9.120800E-01
Grade 3-vs-Grade 4
8.834600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.726000E-01
Normal-vs-NonDiabetic
2.771800E-01
Diabetic-vs-NonDiabetic
8.173200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.364400E-02
Normal-vs-NoPancreatitis
3.476200E-01
Pancreatitis-vs-NoPancreatitis
2.545200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.192000E-01
Normal-vs-N1
5.397400E-01
N0-vs-N1
7.533000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.587400E-01
Normal-vs-TP53-NonMutant
7.668800E-01
TP53-Mutant-vs-TP53-NonMutant
2.371000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
